



Diabetes mellitus (DM) remains the most common metabolic 
disorder worldwide.[1] The hallmark of this disorder 
includes	 the	 abnormally	 high	 level	 of	 triglycerides	 (TGs),	
reduced	 high‑density	 lipoprotein	 (HDL),	 and	 reduced	
low-density lipoprotein (LDL) level.[1] Apart from these, 
hyperglycemia is known to play a contributory role in the 
development of oxidative stress in diabetes.[2] The oxidative 
stress if unchecked has been shown to continuously lead to 
damage to the biological system which eventually leads to 
increased production of markers of lipid peroxidation like 
malondialdehyde (MDA)[3] contributing to the development 
of diabetic complications.[4] The abnormalities in circulating 
lipids and lipoproteins are thus considered to be important risk 
factors for cardiovascular disease in diabetic individuals.[5] 
Reversal	of	 these	abnormalities	 in	 lipid	profile	may	 reduce	
accelerated atherosclerosis and the related macrovascular 
complications in patients with DM.[6]
The use of natural oil and herbal products for disease control 
is the new order, especially in the management of diabetic 
complications and correcting the associated metabolic 
abnormalities.[7] Nigella sativa (NS) (black cumin or black 
seed) is among the natural sources described to have 
therapeutic effects in the management of many diseases.[8] 
Background: Lipid	profile	dysregulation	and	oxidative	stress	are	important	risk	factors	for	cardiovascular	disease	in	diabetic	individuals.	
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enzymes levels in diabetic rats. Methods:	Thirty	(30)	Wistar	rats	were	divided	into	6	groups	of	5	rats	each	as	follows:	Group	I	rats	took	normal	
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The	oil	has	been	widely	reported	to	have	anti‑inflammatory,	
immunomodulatory, anticancer, antiparasitic, antiasthmatic, 
and antihypertensive effects.[9,10] It has also been reported 
to have antidiabetic, analgesic, antimicrobial, spasmolytic, 
bronchodilator, hepatoprotective, renal protective, 
gastroprotective, and antioxidant properties.[11] Moreover, 
the seeds of NS are commonly used in the management of 
various diseases such as bronchitis, diarrhoea, rheumatism, 
and skin disorders.[10] Recently, our team was able to 
establish the therapeutic but non-synergistic effect it has 
when used with Vitamin E (α-tocopherol) in the management 
of cisplatin-induced renal toxicities.[12] Interestingly, 
thymoquinone	which	had	earlier	been	identified	as	the	active	
component in the oil is not only an effective superoxide radical 
scavenger but also protects the liver from toxins.[13]
The hypolipidemic and antioxidative effects of NS oil have 
been demonstrated in experimental animals where it was 
reported	to	have	a	favourable	effect	on	TG	and	lipoprotein	the	
pattern in normal rats.[14]	Similar	findings	were	encountered	
by the administration of thymoquinone, the active ingredient 
of NS, to rabbits fed on cholesterol-enriched diet[15] and to 
hypercholesterolemic rats.[16] Even though the majority of 
authors are of the opinion that NS oil administration improves 
hyperglycemia,[17] oxidative stress, and lipid peroxidation,[18] 
there is a paucity of information on whether this oil should be 
given before the development of diabetes or after, especially 
in individuals with a family history of diabetes. This study, 
therefore, sought to determine the comparative therapeutic 




Ethical approval for this study was granted by the College of 
Medicine of the University of Lagos Animal Care and Use 
Research Ethics Committee with reference number (CMUL/
HREC/02/20/715).
Animals
The study was carried out in adult male Wistar rats weighing 
140–160 g. For acclimatization, the animals were kept in 
the faculty animal house for 2 weeks before the start of the 
experiment. The Wistar rats were kept in wire mesh cages 
under room conditions. The animals were allowed free access 
to water and food pellets at a room temperature of about 
29°C ± 2°C throughout the period of this experiment. They 
had a 12-hour light and 12-hour dark cycle. Experimental 
protocols	complied	with	the	Guide	for	the	Care	and	Use	of	
Laboratory Animals.[19]
Grouping and treatments per group
A total of thirty (30) Wistar rats were divided into 6 groups 
of	 5	 rats	 each	 as	 follows:	Group	 I	 rats	were	 fed	 normal	
rat chow ad libitum without any induction and served as 





V rats were treated with 0.5 ml/kg NS oil intraperitoneally 
after	 diabetes	 induction	 (DB	+	NS0.5)	 and	finally	Group	




This arrangement is illustrated in Table 1.
Induction of diabetes
Diabetes	was	 induced	 in	Groups	 II,	 III,	 IV,	V,	and	VI	by	a	
single intraperitoneal injection of a freshly buffered (0.1 M 
citrate,	pH	4.5)	solution	of	streptozotocin	(STZ)	at	a	dosage	
of 50 mg/kg body weight. After 72 h of STZ administration, 
the tail vein blood was collected to determine blood glucose 
level with the aid of a very sensitive glucometer. Only rats 
with blood glucose over 250 mg/dl were considered diabetic 
and included in the experiments.[20]
Administration of Nigella sativa oil
Groups	III	and	IV	rats	were	preadministered	with	0.5	and	1	
ml of the pure oil, respectively, for 2 weeks intraperitoneally 
before	the	induction	of	diabetes.	Groups	V	and	VI	rats	were	
administered with 0.5 and 1 ml of the pure oil, respectively, 
for 2 weeks intraperitoneally after the induction of diabetes.
Blood sample collection
Each	group	of	animals	was	sacrificed	on	different	days	after	
completion of the expected exposure and treatment periods. 
After overnight fasting, rats were sacrificed following 
euthanization by cervical dislocation.[21]	Blood	was	collected	
via cardiac puncture into EDTA bottles and centrifuged 
immediately at 3000 rpm for 10 min to obtain serum for 
estimation	of	lipid	profile	and	antioxidant	enzymes.
Assessment of lipid profile
TG,	 total	 cholesterol,	HDL,	 and	LDL	 in	 the	 serum	were	
analyzed using a kit meant for animals obtained from Randox 
Laboratories	Limited,	Crumlin,	UK.	This	was	 carried	 out	
using the method of Morakinyo et al.[21] with some minor 
modifications.	To	5	µL of serum, 0.5 mL of enzyme reagent 
was added and kept at 37°C for 5 min. Then, 5 µL of cholesterol 
standard and distilled water (blank) were also processed 
similarly. The absorbance was measured at 510 nm. To 5 µL 
of serum, 0.5 mL of enzyme reagent was added, mixed well, 
and incubated at room temperature for 10 min. Then, 5 µL of 
TG	standard	and	distilled	water	(blank)	were	also	processed	
similarly. The absorbance was measured at 510 nm. LDLs, 
very LDL, and chylomicron fractions were precipitated 
quantitatively in 0.5 mL of serum by the addition of 50 µL 
of	HDL	precipitant	 (phosphotungstic	 acid	 in	 the	 presence	
of magnesium ions). After centrifugation, the cholesterol 
concentration	 in	 the	HDL	 (supernatant)	 fraction	was	 also	
determined.	HDL	and	VLDL	 fractions	were	 eliminated	by	
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cholesterol esterase, cholesterol oxidase, and, subsequently, 
catalase	(CAT).	Thereafter,	the	specific	measurement	of	LDL	
cholesterol marked by the intensity of the quinine imine dye 
produced was measured at 600 nm.
Assessment of antioxidant enzymes level and lipid 
peroxidation
The previously described standard methods[21] were used to 
carry	out	 oxidative	 analyses.	Briefly,	 the	method	described	
by Sun and Zigman[22] was used to determine the activity 
of superoxide dismutase (SOD) enzyme. The reduced 
glutathione	(GSH)	content	of	the	serum	was	measured	using	
the method previously described by van Doorn et al.[23] 
CAT activity was determined by measuring the exponential 
disappearance	of	H2O2 at 240 nm and expressed in units per 
milligram of protein as previously described by Aebi.[24] Lipid 
peroxidation was estimated with the method of Mihara and 
Uchiyama[25] by measuring the level of MDA. Absorbance was 
recorded using a Shimadzu recording spectrophotometer (UV 
160,	Kyoto,	Japan)	in	all	measurements.
Statistical analysis
The data were expressed as mean ± standard error of the mean 
and analyzed using one-way analysis of variance followed 
by	Neumann–Keul	post hoc test. P < 0.05 was considered 
statistically	significant.	Data	analysis	was	carried	out	using	
the GraphPad	Version	 5.05	 for	Windows	Vista	 (GraphPad	
Software, San Diego, CA, USA).
Results
Effect of pre‑ and post‑administration of Nigella sativa 
oil on cholesterol level
Induction	of	diabetes	did	not	cause	a	significant	(P > 0.05) 
change	 in	 the	 cholesterol	 level	 in	 the	DB	group	 compared	
to	control.	Both	pre‑	 and	post‑administration	of	 the	oil	did	
not	 show	any	 significant	 change	 (P > 0.05) in the level of 
cholesterol across all the groups. This is illustrated in Figure 1.
Effect of pre‑ and post‑administration of Nigella sativa 
oil on triglyceride level
As illustrated in Figure 2, the induction of diabetes caused 
a	significant	 (P	<	0.05)	 increase	 in	 the	TG	level	 in	 the	DB	




of	 the	 oil	 caused	 a	 significant	 (P < 0.01) reduction in the 
level	 of	TG	 in	 the	DB	+	NS1	group	 compared	 to	 the	DB	
group.	 Post‑administration	 in	 the	DB	 +	NS1	 group	was	
also	more	effective	to	cause	reduction	than	the	DB	+	NS0.5	
group (P	 <	 0.01).	 Post‑administration	 of	NS	oil,	 however,	
did	not	significantly	(P	>	0.05)	change	the	level	of	TG	in	the	
DB	+	NS0.5	group	compared	to	the	DB	group.
Effect of pre‑ and post‑administration of Nigella sativa oil 
on high‑density lipoprotein level
There	was	 a	 slight	 reduction	 in	 the	 level	 of	HDL,	but	 this	
reduction	was	 statistically	 not	 significant	 (P > 0.05) in the 
DB	group	compared	to	the	control	group.	Pre‑administration	
with	NS	oil	 in	 the	NS0.5	+	DB	group	caused	a	 significant	
increase (P	 <	 0.05)	 in	 the	HDL	 level	 compared	 to	 the	DB	
group.	Post‑administration	with	NS	oil	in	the	DB	+	NS0.5	and	
DB	+	NS1	groups	also	caused	a	significant	increase	(P < 0.05) 
in	the	HDL	level	compared	to	the	DB	group.	This	is	illustrated	
in Figure 3.
Effect of pre‑ and post‑administration of Nigella sativa oil 
on low‑density lipoprotein level
Induction	of	diabetes	did	not	cause	a	significant	(P > 0.05) change 
in	 the	LDL	level	 in	 the	DB	group	compared	 to	control.	Both	
pre‑	and	post‑administration	of	NS	oil	did	not	show	any	significant	
Table 1: Animal groups
Group Group name Induction Pre‑treatment Post‑treatment
I Control Distilled water No treatment No treatment
II Diabetic	(DB) STZ-induced diabetes No treatment No treatment
III NS0.5	+	DB STZ-induced diabetes N. sativa 0.5 ml ip No treatment
IV NS1	+	DB STZ-induced diabetes N. sativa 1 ml ip No treatment
V DB	+	NS0.5 STZ-induced diabetes No treatment N. sativa 0.5 ml ip
VI DB	+	NS1 STZ-induced diabetes No treatment N. sativa 1 ml ip
STZ:	Streptozotocin,	NS:	Nigella sativa,	ip:	Intraperitoneal,	N. sativa: Nigella sativa
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Figure 1: Cholesterol level across the groups. Values are represented 
as mean ± standard error of the mean. Group I: Control (CTRL), 
Group II: Diabetic (DB), Group III: Nigella sativa group pretreated with 
0.5 ml (NS0.5 + DB), Group IV: Nigella sativa group pretreated with 
1ml (NS1 + DB), Group V: Nigella sativa group post‑treated with 
0.5 ml (DB + NS0.5), Group VI: Nigella sativa group post‑treated with 
1 ml (DB + NS1)
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change (P > 0.05) in the level of LDL across all the groups even 
though there appears to be a general reduction in the pre- and post-
treatment groups. This is illustrated in Figure 4.
Effect of pre‑ and post‑administration of Nigella sativa 
oil on atherogenic index
Induction	of	diabetes	did	not	cause	a	significant	(P > 0.05) 
change	in	the	atherogenic	index	in	the	DB	group	compared	
to	control.	Both	pre‑and	post‑administration	of	the	oil	did	not	
show	any	significant	change	(P > 0.05) in the atherogenic index 
across all the groups. This is illustrated in Figure 5.
Effect of pre‑ and post‑administration of Nigella sativa oil 
on reduced glutathione level




NS0.5+DB	group	caused	a	statistically	significant	(P < 0.05) 
increase	 in	GSH	 level	when	compared	with	 the	DB	group.	
Pre‑administration	of	the	oil	in	the	NS1+DB	group,	however,	
did	not	cause	a	statistically	significant	(P > 0.05) difference in 
GSH	level	when	compared	with	DB	group.	post‑administration	
of NS	in	the	DB	+	NS0.5	and	the	DB	+	NS1	groups	also	did	
not	cause	a	 statistically	 significant	 (P > 0.05) difference in 
GSH	level	when	compared	with	DB	group.
Effect of pre‑and post‑administration of Nigella sativa oil 
on superoxide dismutase level
The level of SOD was not statistically different (P	>	0.05)	in	the	DB	group	
compared	to	control.	Pre‑administration	of	the	oil	in	the	NS0.5	+	DB	
and	NS1	+	DB	groups	caused	a	statistically	significant	(P < 0.01) 
increase	in	SOD	level	when	compared	with	the	DB	group.	In	a	similar	
manner,	post‑administration	of	the	oil	in	the	DB	+	NS0.5	and	DB	+	NS1	
groups	caused	a	statistically	significant	(P < 0.01) increase in SOD level 
when	compared	with	the	DB	group.
Effect of pre‑ and post‑administration of Nigella sativa 
oil on catalase level




and	DB	+	NS1	groups	caused	a	significant	increase	(P < 0.01, 
P < 0.01, and P < 0.001, respectively) in the CAT level. CAT 
level	was	also	found	not	to	be	significantly	different	(P > 0.05) 
in	the	NS1	+	DB	group	compared	to	the	DB	group.
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Figure 3: High‑density lipoprotein level across the groups. Values are 
represented as mean ± standard error of the mean. *: Significant 
increase (P < 0.05) versus DB group. µ: Significant increase (P < 0.01) 
versus Control group. Group I: Control (CTRL), Group II: Diabetic (DB), 
Group III: Nigella sativa group pretreated with 0.5ml (NS0.5 + DB), Group 
IV: Nigella sativa group pretreated with 1 ml (NS1 + DB), Group V: Nigella 
sativa group post‑treated with 0.5 ml (DB + NS0.5), Group VI: Nigella 
sativa group post‑treated with 1 ml (DB + NS1)
Figure 2: Triglyceride level across the groups. Values are represented as 
mean ± standard error of the mean. *: Significant increase (p < 0.05) 
versus Control group. µ: Significant reduction (P < 0.01) versus DB 
group, β: Significant reduction (P < 0.01) versus DB + NS0.5 group. 
Group I: Control (CTRL), Group II: Diabetic (DB), Group III: Nigella sativa 
group pretreated with 0.5 ml (NS0.5 + DB), Group IV: Nigella sativa 
group pretreated with 1 ml (NS1 + DB), Group V: Nigella sativa group 
post‑treated with 0.5 ml (DB + NS0.5), Group VI: Nigella sativa group 
post‑treated with 1 ml (DB + NS1)
Table 2: Antioxidant levels across the groups
CTRL DB NS0.5±DB NS1±DB DB±NS0.5 DB±NS1
GSH	(µmol/ml) 13.65±0.82 9.65±1.58 20.57±1.73* 15.19±2.75 15.85±1.11 18.6±2.03
SOD	(µmol/ml) 60.46±5.43 60.93±2.64 81.19±2.74** 78.91±4.29** 84.62±5.00** 82.10±4.35**
CAT	(µmol/ml) 439.60±59.69 372.10±27.44 615.90±58.95** 455.60±45.50 475.80±36.40** 687.81±38.47***α,β.µ
MDA	(µmol/ml) 3.64±0.68 5.23±0.46δ 4.52±0.6* 3.52±0.41** 3.46±0.49** 3.42±0.69***
Values	are	represented	as	mean±SEM.	Significant,	*P<0.05, **P<0.01, ***P<0.001	versus	DB	group,	βSignificant	increase	(P<0.01)	versus	NS1	+	DB,	
µSignificant	increase	(P<0.01)	versus	DB	+	NS0.5,	δP<0.05	versus	control	group.	Group	I:	Control	(CTRL),	Group	II:	Diabetic	(DB),	Group	III:	N. sativa 
group	pretreated	with	0.5	ml	(NS0.5	+	DB),	Group	IV:	N. sativa	group	pretreated	with	1	ml	(NS1	+	DB),	Group	V:	N. sativa group posttreated with 0.5 ml 
(DB	+	NS0.5),	Group	VI:	Nigella sativa	group	posttreated	with	1	ml	(DB	+	NS1).	GSH:	Reduced	glutathione,	SOD:	Superoxide	dismutase,	CAT:	Catalase,	
MDA:	Malondialdehyde,	N. sativa:	Nigella sativa,	SEM:	Standard	error	of	mean
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Effect of pre‑ and post‑administration of Nigella sativa oil 
on malondialdehyde level
The level of MDA was significantly higher (P < 0.05) 
in	 the	 DB	 group	 compared	 to	 control.	MDA	 level	 was	
significantly	(P	<	0.05)	lower	in	the	NS0.5	+	DB	and	NS1	+	DB	
groups (P	<	0.01)	compared	to	DB	group.	MDA	level	was	also	
found	to	be	markedly	reduced	in	the	DB	+	NS0.5	(P < 0.01) 
and	DB	+	NS1	groups	when	compared	with	the	DB	group.
dIscussIon
Even with the advancement in the management of DM, 
exploration for innovative agents continues since the existing 
synthetic agents have numerous limitations.[26] Even though 
NS	oil	has	been	shown	to	have	a	lot	of	beneficial	effects;	it	is	
crucial to decide whether it should be used as a protective or 
corrective	agent.	This	study	is,	thus,	the	first	to	compare	the	
pre- and post-treatment effects in an animal model of DM.
Cholesterol level appeared to be high in the diabetes group, 
while neither pre-treatment nor post-treatment with the oil 
had a significant effect on the level. Increased serum total 
cholesterol concentrations are directly associated with an 
increased risk of coronary heart disease.[27]	Both	pre‑	and	
post-treatment with the oil slightly reduced the cholesterol 
level, and this effect may be due to de novo cholesterol 
synthesis inhibition or stimulation of excretion of bile 
acid. It is well known that both effects would lead to a 
decrease in serum cholesterol.[28,29] The slight reduction 
could also be due to the presence of phytosterols such 
as beta-sitosterol, polyunsaturated fatty acids, and their 
antioxidant activity.[30,31] These results further confirmed 
earlier reports that NS oil could be used as an adjunct 
therapy for glycemic control[28] either for prevention or 
correction of high glucose level.
The	 level	 of	TG	was	 observed	 to	 be	 significantly	 high	 in	
the	DB	group	 in	 this	 study.	Elevated	TG	 level	 is	 no	doubt	
a risk factor[32] for atherosclerosis and this could be due to 
decreased	clearance	 rate	of	TG.[33] It is worthy of note that 
post‑treatment	with	the	oil	caused	a	significant	reduction	in	
the	TG	 level,	while	 the	effect	appears	 to	be	minimal	when	
given	before	the	induction.	Kocyigit	et al.[14] had demonstrated 
the hypolipidemic potential of the oil when used in diabetic 
rats,	and	our	 result	 further	confirmed	 this	earlier	 result	and	
others.[15,16]
Our results also showed the ability of the oil to cause a marked 
improvement	in	the	level	of	HDL	when	used	either	before	or	
after diabetes induction. This is a pointer to the ability of the 
oil	to	either	prevent	or	correct	the	HDL	level	in	diabetes.	This	
observation	is	in	line	with	the	result	of	Kaatabi	et al.[33]	HDL	is	a	
key lipoprotein that helps remove lipids from macrophage foam 
cells in the arterial wall and thereby offer useful protection 
from LDL oxidation.[34] Surprisingly, the obvious reductions 
observed in the LDL in pre- and post-treated rats were found 
not	to	be	statistically	significant.	In	essence,	there	is	no	obvious	
mechanism to explain the antiatherogenic pattern of lipoprotein 
profile	found	in	the	present	study	following	oil	pre‑	or	post‑
treatment. This could, however, mean the non-preference of 
pre-treatment over post-treatment and vice-versa. Our study 
also showed the ability of post-treatment to ameliorate the 
atherogenic index compared to the pre-treatment slightly. 
Based	on	the	results	of	this	study,	neither	pre‑treatment	nor	
post-treatment of the oil can, thus, be guaranteed as a treatment 
option usable to correct this cardiovascular risk factor.




caused a marked improvement in the level of SOD and CAT. 
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Figure 4: Low‑density lipoprotein level across the groups. Values 
are represented as mean ± standard error of the mean. Group I: 
Control (CTRL), Group II: Diabetic (DB), Group III: Nigella sativa group 
pretreated with 0.5ml (NS0.5+DB), Group IV: Nigella sativa group 
pretreated with 1ml (NS1+DB), Group V: Nigella sativa group post‑treated 
with 0.5 ml (DB+NS0.5), Group VI: Nigella sativa group post‑treated 
with 1 ml (DB+NS1)
Figure 5: Atherogenic index across the groups. Values are 
represented as mean ± standard error of the mean. Group I: 
Control (CTRL), Group II: Diabetic (DB), Group III: Nigella sativa group 
pretreated with 0.5 ml (NS0.5+DB), Group IV: Nigella sativa group 
pretreated with 1ml (NS1+DB), Group V: Nigella sativa group post‑treated 
with 0.5 ml (DB+NS0.5), Group VI: Nigella sativa group post‑treated 
with 1 ml (DB+NS1)
Busari, et al.: Pre‑ and posttreatment effects of Nigella sativa oil
It is interesting to know that both pre-treatment and post-
treatment with the oil also caused a marked reduction in the 
level of MDA. In agreement with some of these observations, 
Omidi et al.[35] reported a significant improvement in 
antioxidant parameters in diabetic rats following NS oil 
administration.	Also,	 Pencina	et al.[36] reported a reduction 
in MDA following NS oil administration, and this was also 
the observation made by El Rabey et al.[37] It does mean that 
both pre- and post-treatment with NS oil have the potential to 
improve the antioxidant system and reduce lipid peroxidation, 
but the post-treatment appears to be more effective. Contrary to 
these observations, however, the dietary black seed had been 
shown	not	to	significantly	affect	TAS,	SOD,	and	GPX	levels	
in hyperlipidemic rabbits.[38]	This	 finding	 could,	 however,	
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